Avecho Biotechnology Ltd has released a press release.
Annual Report 31 December 2025
Filed with ASX ·
6ix hasn’t read this filing yet.
Avecho Biotechnology Limited on 6ix
Story so far
Earlier from Avecho Biotechnology
- December 2025 Quarterly Activities Report & Appendix 4C
- Phase III CBD Clinical Trial Recruitment Update
- AVE Secures US & EU Patent Allowances for CBD Soft-Gel
- September 2025 Quarterly Activities Report & Appendix 4C
- Avecho raises $2.5m via placement
Later from Avecho Biotechnology
- Avecho completes recruitment for Phase III interim analysis
- March 2026 Quarterly Activities Report & Appendix 4C
- Expiry of Listed Options
- Avecho completes treatment for Phase III interim analysis
- Receipt of Research & Development Tax Incentive
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology